Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy

Journal of Gastrointestinal and Liver Diseases

Volumn 21, Issue 2, 2012, Pages 139-143

  Yamada, Hideto ^a   Tahara, Tomomitsu ^b   Shiroeda, Hisakazu ^a   Hayashi, Ranji ^a   Saito, Takashi ^a   Nakamura, Masakatsu ^a   Tsuchishima, Mutsumi ^a   Tsutsumi, Mikihiro ^a   Shibata, Tomoyuki ^b   Arisawa, Tomiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Chronic gastritis; Genetic polymorphism; Helicobacter pylori infection; Histamine H2 receptor

Indexed keywords

GENOMIC DNA; HISTAMINE; HISTAMINE H2 RECEPTOR; PEPSINOGEN;

ADULT; ARTICLE; ATROPHY; CHRONIC GASTRITIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR; SEROLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH MUCOSA;

ADULT; AGE FACTORS; AGED; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, HISTAMINE H2; SEVERITY OF ILLNESS INDEX;

EID: 84863429765     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chen D, Aihara T, Zhao CM, Hakanson R, Okabe S. Differentiation of the gastric mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: understanding gastric physiology through disruption of targeted genes. Am J Physiol Gastrointest Liver Physiol 2006; 291: G539-G544.
2. Rangachari PK. Histamine: mercurial messenger in the gut. Am J Physiol 1992; 262: G1-G13.
3. Hill SJ, Ganellin CR, Timmerman H, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997; 49: 253-278.
4. Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature 1972; 236: 385-390.
5. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-1127.
6. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcer. Lancet 1984; 1: 1311-1315.
7. McColl KE, El-Omar E, Gillen D. Interactions between H pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull 1998; 54: 121-138.
8. Courillon-Mallet A, Launay JM, Roucayrol AM, et al. Helicobacter pylori infection: physiopathologic implication of N alpha-methyl histamine. Gastroenterology 1995; 108: 959-966.
9. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-938.
10. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998; 54: 139-150.
11. Mancama D, Arranz MJ, Munro J, et al. Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett 2002; 333: 207-211.
12. Garcia-Martin E, Ayuso P, Luengo A, Martinez C, Agundez JA. Genetic variability of histamine receptors in patients withParkinson's disease. BMC Med Genet 2008; 9: 15.
13. Arisawa T, Tahara T, Shibata T, et al. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med 2007; 19: 143-148.
14. Shiroeda H, Tahara T, Shibata T, et al. Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases. Int J Mol Med 2010; 26: 707-711.
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-1181.
16. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-2851.
17. Pestov DG, Strezoska Z, Lau LF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001; 21: 4246-4255.
18. Ito C, Morisset S, Krebs MO, et al. Histamine H2 receptor gene variants: lack of association with schizophrenia. Mol Psychiatry 2000;5: 159-164.
19. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740.
20. Fox JG, Rogers AB, Ihrig M, et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003; 63: 942-950.
21. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36-47.
22. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995; 90: 1401-1406.
23. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophag itis treated with omeprazole or fundoplication. N Engl J Med 1996; 334:1018-1022.
24. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997; 41: 740-747.
25. Takaishi S, Cui G, Frederick DM, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacterinduced gastric cancer. Gastroenterology 2005; 128: 1965-1983.
26. Brenna E, Swarts HG, Klaassen CH, de Pont JJ, Waldum HL. Evaluation of the trophic effect of longterm treatment with the histamine H2 receptor antagonist loxtidine on rat oxyntic mucosa by differential counting of dispersed cells. Gut 1994; 35: 1547-1550.
27. Hunyady B, Zolyomi A, Czimmer J, et al. Expanded parietal cell pool in transgenic mice unable to synthesize histamine. Scand J Gastroenterol 2003; 38: 133-140.